Laura Genatossio

Laura Pala Genatossio was named senior vice president and general manager, Europe, in October 2021. In this role, she is responsible for building and leading the European business strategy and operations for Urovant Sciences GmbH and is based at the company’s European headquarters office in Basel, Switzerland.

Prior to joining Urovant, Ms. Genatossio served as vice president and general manager Europe, Middle East, and Africa for Sarepta Therapeutics, where she was responsible for leading regional strategy and operations, including medical affairs, G&A, local commercial, market access, and patient affairs. Prior to her move to Switzerland, Ms. Genatossio built the global strategic marketing capabilities and the team at Sarepta.

Previously, Ms. Genatossio held global strategic marketing roles with Aegerion Pharmaceuticals and served as interim country manager for Aegerion in Canada. Earlier in her career, she held brand leadership roles for Astra Zeneca in Europe for the company’s oncology and cardiovascular portfolios.

Ms. Genatossio earned an MBA in Marketing, with honor, from the University of Massachusetts College of Management, and a Bachelor of Arts in Business Law, with honors, from Bologna University.